Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -75,305 | N/A | N/A |
| Depreciation Amortization | 350 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,000 | N/A | N/A |
| Other Working Capital | 4,310 | N/A | N/A |
| Other Operating Activity | 1,512 | 0 | 0 |
| Operating Cash Flow | $-66,133 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 242,475 | N/A | N/A |
| PPE Investments | -7,982 | N/A | N/A |
| Purchase Of Investment | -553,517 | N/A | N/A |
| Investing Cash Flow | $-319,024 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 613 | N/A | N/A |
| Other Financing Activity | 4,993 | 0 | 0 |
| Financing Cash Flow | $5,606 | $N/A | $N/A |
| Beginning Cash Position | 422,383 | N/A | N/A |
| End Cash Position | 42,832 | N/A | N/A |
| Net Cash Flow | $-379,551 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -66,133 | N/A | N/A |
| Capital Expenditure | -8,002 | N/A | N/A |
| Free Cash Flow | -74,135 | 0 | 0 |